Atria Wealth Solutions’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,006
Closed -$227K 1736
2025
Q1
$227K Buy
8,006
+211
+3% +$5.98K ﹤0.01% 1641
2024
Q4
$324K Buy
7,795
+1,694
+28% +$70.4K ﹤0.01% 1480
2024
Q3
$408K Sell
6,101
-21,307
-78% -$1.42M ﹤0.01% 1332
2024
Q2
$3.25M Buy
27,408
+20,064
+273% +$2.38M 0.04% 459
2024
Q1
$783K Sell
7,344
-32
-0.4% -$3.41K 0.01% 1017
2023
Q4
$734K Sell
7,376
-83
-1% -$8.25K 0.01% 1004
2023
Q3
$770K Sell
7,459
-3,585
-32% -$370K 0.01% 924
2023
Q2
$1.34M Sell
11,044
-4,038
-27% -$491K 0.02% 717
2023
Q1
$2.32M Buy
15,082
+1,862
+14% +$286K 0.03% 495
2022
Q4
$2.37M Sell
13,220
-1,702
-11% -$306K 0.04% 451
2022
Q3
$1.76M Sell
14,922
-941
-6% -$111K 0.03% 525
2022
Q2
$2.27M Sell
15,863
-18
-0.1% -$2.57K 0.04% 384
2022
Q1
$2.74M Buy
+15,881
New +$2.74M 0.05% 394